tiprankstipranks
Trending News
More News >
CanSino Biologics, Inc. Class H (HK:6185)
:6185

CanSino Biologics, Inc. Class H (6185) Revenue

Compare
2 Followers

CanSino Biologics, Inc. Class H Revenue

CanSino Biologics, Inc. Class H had a revenue of 279.26M in the quarter ending Dec 31, 2024, with 5.92%. This bring the company's revenue in the last twelve months to 828.33M, Decreased 15.27%. In the fiscal year ending Dec 31, 2024, CanSino Biologics, Inc. Class H had annual revenue of 846.34M with 145.19% growth.
Revenue (ttm)
828.33M
Revenue Growth
94.98%
P/S Ratio
12.86
Revenue/Employee
HK$765,917
Employees
1,105
Market Cap
HK$10.89B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
846.34M501.16M+145.19%
Dec 31, 2023
345.18M-685.86M-66.52%
Dec 31, 2022
1.03B-3.27B-76.02%
Dec 31, 2021
4.30B4.28B+23,086.49%
Dec 31, 2020
18.54M16.26M+712.13%
Dec 31, 2019
2.28M1.15M+101.71%
Dec 31, 2018
1.13M-8.05M-87.67%
Dec 31, 2017
9.18M987.00K+12.04%
Dec 31, 2016
8.20M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis